![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, August 31, 2019 11:47:50 AM
It is the use of the transdermal technology to deliver medications across the skin to treat conditions more effectively and with a lower risk of side effects. That is the premise.
When you look at the actual business practices of VDRM it is a horror show. It is a stark contrast between the wished for fantasy we longs invested in and the sordid reality we bagholders (stuckholders) face here at VDRM.
Since the stock price is so low, why not keep the fantasy alive since it costs so little now to hold on? That is the reason we don’t sell even when any reasonable person would have given up hope long ago.
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM